Viking looks long term [Yahoo! Finance]

Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
This story was originally published on BioPharma Dive . To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter For any hopes the dealmaking that started the J.P. Morgan Healthcare Conference would give the overall biotechnology sector a running start to 2025, Eli Lilly deflated them Tuesday. The company, which rose to new heights on the success of its medicines for weight loss and diabetes, revealed revenue numbers that for the second time in a row fell short of investor expectations. Lilly shares fell 7% and dragged with them the stocks of several other obesity drug developers. A biotech stock index slid by almost 3%. Amgen is one of those would-be competitors and, at the JPM meeting, executives defended recent trial results for the company's rival weight loss drug. Read on for details on that and other highlights from the conference: Amgen's MariTide defense Amgen's market value rose and fell by billions of dollars last year on the promi
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Viking Therapeutics, Inc. (NASDAQ: VKTX) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $102.00 price target on the stock.MarketBeat
- Why Viking Therapeutics Inc. (VKTX) Went Down on Monday [Yahoo! Finance]Yahoo! Finance
- 2 Stocks to Buy With Less Than $40 [Yahoo! Finance]Yahoo! Finance
- 2 Stocks That Could Soar Again in 2025 [Yahoo! Finance]Yahoo! Finance
- Down 65%, Is Viking Therapeutics Stock a Buy on the Dip? [Yahoo! Finance]Yahoo! Finance
VKTX
Earnings
- 2/5/25 - Miss
VKTX
Sec Filings
- 2/5/25 - Form 8-K
- 2/4/25 - Form SCHEDULE
- 1/6/25 - Form 4
- VKTX's page on the SEC website